These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 25240012)

  • 1. Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel-releasing intrauterine system in women without previous vaginal delivery: a RCT.
    Castro TV; Franceschini SA; Poli-Neto O; Ferriani RA; Silva de Sá MF; Vieira CS
    Hum Reprod; 2014 Nov; 29(11):2439-45. PubMed ID: 25240012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT.
    Bahamondes MV; Espejo-Arce X; Bahamondes L
    Hum Reprod; 2015 Aug; 30(8):1861-6. PubMed ID: 26040478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracervical block for levonorgestrel-releasing intrauterine system placement among nulligravid women: a randomized double-blind controlled trial.
    De Nadai MN; Poli-Neto OB; Franceschini SA; Yamaguti EMM; Monteiro IMU; Troncon JK; Juliato CRT; Santana LF; Bahamondes L; Vieira CS
    Am J Obstet Gynecol; 2020 Mar; 222(3):245.e1-245.e10. PubMed ID: 31541635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
    Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
    Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of naproxen versus intracervical block for pain control during the 52-mg levonorgestrel-releasing intrauterine system insertion in young women: a multivariate analysis of a randomized controlled trial.
    de Oliveira ECF; Baêta T; Brant APC; Silva-Filho A; Rocha ALL
    BMC Womens Health; 2021 Oct; 21(1):377. PubMed ID: 34715839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain at insertion of the levonorgestrel-releasing intrauterine system in nulligravida and parous women with and without cesarean section.
    Santos AR; Bahamondes MV; Hidalgo MM; Atti A; Bahamondes L; Monteiro I
    Contraception; 2013 Jul; 88(1):164-8. PubMed ID: 23507169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
    Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
    Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain scores at the insertion of the 52 MG levonorgestrel-releasing intrauterine system among nulligravidas and parous women.
    Chaves IA; Baêta T; Dolabella GB; Barbosa LR; Almeida NM; Oliveira FR; Oliveira EC; L Silva-Filho A; Rocha ALL
    Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):399-403. PubMed ID: 34096433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
    Wildemeersch D; Janssens D; Weyers S
    Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies.
    Apter D; Gemzell-Danielsson K; Hauck B; Rosen K; Zurth C
    Fertil Steril; 2014 Jun; 101(6):1656-62.e1-4. PubMed ID: 24726226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
    Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
    Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of insertion of levonorgestrel-releasing intrauterine system: a randomised controlled trial.
    van der Heijden P; Geomini P; Herman MC; Veersema S; Bongers MY
    BJOG; 2017 Jan; 124(2):299-305. PubMed ID: 28012273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women.
    Ferreira LS; de Nadai MN; Poli-Neto OB; Franceschini SA; Juliato CRT; Monteiro IMU; Bahamondes L; Vieira CS
    Contraception; 2020 Oct; 102(4):267-269. PubMed ID: 32679045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system.
    Heikinheimo O; Inki P; Kunz M; Parmhed S; Anttila AM; Olsson SE; Hurskainen R; Gemzell-Danielsson K
    Contraception; 2010 Jun; 81(6):481-6. PubMed ID: 20472114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactional changes in short-term levonorgestrel-releasing intrauterine system (lng-ius) use.
    Giraldo PC; Souza TC; Henrique GL; Monteiro I; Amaral R; Machado RB; Discacciati MG; Sanches JM
    Rev Assoc Med Bras (1992); 2019 Jul; 65(6):857-863. PubMed ID: 31340317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.